Business
GE HealthCare Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation
Latest digital platform provides key advancements to help maintain high signal fidelity while reducing environmental noise Forward-looking platform designed
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":"\n\nLatest digital platform provides key advancements to help maintain high signal fidelity while reducing environmental noise\n\n\n\nForward-looking platform designed to help enable path to new technologies in the electrophysiology (EP) lab\n\n\n\n CHICAGO--(BUSINESS WIRE)--\nGE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias.\n\n\nCardiovascular disease is the leading cause of death globally - affecting millions of individuals and placing a significant burden on healthcare systems today. 1 Within the complex umbrella of cardiology care and cardiovascular disease, atrial fibrillation (AFib) is the most common arrhythmia diagnosed in clinical practice with projections indicating that the prevalence of AFib could reach 15.9 million people in the United States by 2050 and 17.9 million in Europe by 2060.2 For those living with cardiac arrhythmias like AFib, the longer a person is living out of rhythm, the more difficult the arrhythmia is to treat and the more dangerous it may become. If diagnosed early, rhythm control treatment can reduce AFib recurrence and potentially prevent progression.3\n\n\nElectrophysiology labs play a pivotal role in the treatment of cardiac arrhythmias like AFib and require sophisticated recording systems to capture and analyze intracardiac signals accurately. GE HealthCare’s latest Prucka 3 with CardioLab EP Recording system builds on more than twenty years of success in the field of electrophysiology to provide a robust ecosystem of mapping technologies that help provide accurate, efficient, and advanced analytics for the diagnosis and treatment of cardiac arrhythmias.\n\n\nThe system’s digital platform maintains high signal fidelity, while reducing environmental noise through new signal-filtering capabilities and enhanced software for powerline noise reduction.4 The forward-looking platform also provides a path to emerging technologies in electrophysiology that depend on quality signals for their fast interpretation and clinical results.\n\n\n“Signal clarity is key in the EP Lab,” shares Dr. Usman Siddiqui, Director of Electrophysiology.5 “With the launch of the latest Prucka 3 digital amplifier, I feel confident analyzing critical signals regardl...